Skip to content

The effects of krill oil on resistance exercise

The effects of krill oil supplementation combined with resistance training on body composition and athletic performance

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN11524409
Enrollment
21
Registered
2017-10-31
Start date
2016-03-15
Completion date
Unknown
Last updated
2018-11-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy volunteers Nutritional, Metabolic, Endocrine Healthy volunteers

Interventions

Participants undergo a resistance training program (programmed, non-linear training split) four days per week for a period of 8 weeks. Participants are allocated to one of two groups. Those in the f

Sponsors

Rimfrost USA
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: 1. Males 18 to 30 years of age 2. Resistance training at least 2 times per week for the past six months 3. Minimum of 1 year of training experience active 4. Currently resistance training

Exclusion criteria

Exclusion criteria: 1. Free of musculoskeletal, metabolic, and respiratory disorders 2. Free of cardiovascular disease 3. No musculoskeletal injuries with the last six months 4. No history of smoking or drug use 5. No history of excessive alcohol consumption 6. Not taking prescription medication 7. Have not used a fish oil-, thermogenic-, protein-, amino acid-, or creatine supplement within the prior two months 8. Have not habitually used caffeine (e.g. more than 2 cups of coffee per day)

Design outcomes

Primary

MeasureTime frame
1. Body composition is measured using the whole-body Dual-Energy X-ray Absorptiometry (DXA) at baseline and 8 weeks 2. Strength is measured using one repetition maximum (1RM) on a bench press and leg press at baseline and 8 weeks

Secondary

MeasureTime frame
1. Perceptual Measures is measured using perceived recovery at beginning and end of every week 2. Cognition is measured using a Stroop Test at baseline and eight weeks 3. Safety is measured using comprehensive metabolic panel (CMP) at baseline and eight weeks 4. Complete blood count (CBC) and lipid panels is measured using blood tests at baseline and eight weeks

Countries

United States of America

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026